Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7362 ↗At a glance
Fallbericht in Journal of Drugs in Dermatology, 2023. Written by Enz Paula and 7 co-authors. Major MEDLINE topics: Calciphylaxis, Thiosulfates. Cited 1 times so far (Crossref).
Abstract (original language)
Calciphylaxis is a rare disease characterized by calcification of the middle layer of small arteries and arterioles, causing secondary cuta-neous ischemia. The diagnosis is clinical but may be confirmed by histological examination. The optimal treatment is not exactly known, although there is consensus that a multifactorial approach is required. This report is regarding the case of a female patient with a kidney transplant requiring peritoneal dialysis, in the late postoperative period of partial parathyroidectomy due to severe hyperparathyroidism, with refractory hypocalcemia and severe calciphylaxis, subsequently treated with intralesional sodium thiosulfate due to initial intoler-ance to intravenous thiosulfate treatment. J Drugs Dermatol. 2023;22(12):e28-e30. doi:10.36849/JDD.7362e.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Paula, E., Denys, P., Anamá, D. P., María, D., Carolina, V., Ana, T., Luis, M., & Guido, M. C. (2023). Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7362
Vancouver
Paula E, Denys P, Anamá DP, María D, Carolina V, Ana T, et al. Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7362
BibTeX
@article{Paula2023,
author = {Paula, Enz and Denys, Peñaloza and Anamá, Di Prinzio and María, Diehl and Carolina, Vazquez and Ana, Torre and Luis, Mazzuoccolo and Guido, Musso Carlos},
title = {Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7362}
}
EUVIMED